There
are several vascultic disorders still labeled as difficult-to-treat conditions
due to its rarity and complexity at the time of presentation. The need for
effective treatment for vasculitis is demanding since it carries a high
incidence of morbidity and mortality either as a long term consequence of the
disease itself or from the therapeutic interventions.
 |
| Anti TNF-α Therapy |
However, the available
studies to provide evidence of therapies to practicing clinicians are mostly
based on non-randomized controlled trials. Conducting a well-controlled
randomized clinical trial is difficult due to multiple limitations; for
example, failure to establish a measurable endpoint in vascultic disorders
leads to different endpoints, making it difficult to obtain evidence from these
trials. Read More>>>>>>>>>>
No comments:
Post a Comment